ClinicalTrials.Veeva

Menu

Prednisolone in Infantile Spasms- High Dose Versus Usual Dose

L

Lady Hardinge Medical College

Status and phase

Completed
Phase 3

Conditions

Infantile Spasms
West Syndrome

Treatments

Drug: Oral prednisolone

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Infantile spasms comprise a difficult to treat type of epilepsy in young children. Hormonal treatment, i.e. Prednisolone and ACTH are considered the treatment of choice. There is no consensus on the dosage of Prednisolone required for the treatment of infantile spasms. Recent data has shown that a high dose (4 mg/kg/day) may be more efficacious than the usual dose (2 mg/kg/day). However, there are no randomized controlled trials comparing these doses. A higher steroid dose may also be associated with more side effects. Therefore, this study was planned to compare the efficacy and tolerability of the high dose versus the usual dose in children with infantile spasms, in a randomized open-label trial design

Enrollment

63 patients

Sex

All

Ages

3 to 24 months old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Children aged 3 months to 2 years presenting with epileptic spasms (at least 1 cluster/day) with EEG evidence of hypsarrhythmia or its variants

Exclusion criteria

  1. Children with active systemic illness
  2. Children with evidence of active tuberculosis
  3. Severe Acute Malnutrition ad defined by WHO (visible wasting/Mid Upper Arm Circumference < 11 cm/pedal edema/Weight for height < 3 SD)
  4. Children with recurrent illness/chronic systemic illness

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

63 participants in 2 patient groups

High dose
Experimental group
Description:
Oral Prednisolone will be given at dose of 4 mg/kg/day for 14 days
Treatment:
Drug: Oral prednisolone
Usual dose
Active Comparator group
Description:
Oral prednisolone will be given at dose of 2 mg/kg/day for 14 days
Treatment:
Drug: Oral prednisolone

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems